Moleculin Biotech, Inc. MBRX
Regular-session close
After hours · Nov 13, 4:00 PM ET
- YTD
- +137.76%
- 1 year
- -30.66%
Discussion (205)
Sign in to join the discussion
The Only one green ticker in my Portfolio today
What’s your agenda, ‘JT’?
Upcoming Milestones Expectations
H2 2021: Report cohort topline results from the ongoing Phase 1/2 study for treatment of AML and report the study's topline results.
H2 2021: Commence Phase 1/2 study in Europe for the treatment of AML evaluating combination therapy of Annamycin + AraC.
H2 2021: Commencement of an investigator-funded, second Phase 1b/2 clinical trial of Annamycin in sarcoma lung metastases in Europe
I picked a higher entry price for a ton of this and I don’t care what the sp does for the next 6-12 months either way and base the investment on the aggregate potential and re-confirmation periodically. I check in about every 2 months here for any useful info but find increasingly more bs posts designed for penny ante short bets. See you in August.
Calm before the storm, investors are already in thus only volume is generated by temporary short euphoria
Is it trading today or halted?
Will be happy to see 15$ by year end
I own far more shares than traded so far today.
We’re in the throws of manipulation to drive sp down-I went through same thing with Immunomedics and I averaged down below $3 and then tendered close to $2MILLION in the Gild buyout at $88 sp . Playing with house money now. Have fun while you can because I don’t care.
2-H play forward, always has been! Fools play now.
